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O B J E C T I V E S The purpose of this study was to assess the relationship of left atrial (LA) phasic
volumes and LA reservoir function with subclinical cerebrovascular disease in a stroke-free community-
based cohort.
B A C KG ROUND An increase in LA size is associated with cardiovascular events including stroke.
However, it is not known whether LA phasic volumes and reservoir function are associated with
subclinical cerebrovascular disease.
METHOD S The LA minimum (LAVmin) and maximum (LAVmax) volumes, and LA reservoir function,
measured as total emptying volume (LAEV) and total emptying fraction (LAEF), were assessed by
real-time 3-dimensional echocardiography in 455 stroke-free participants from the community-based
CABL (Cardiovascular Abnormalities and Brain Lesions) study. Subclinical cerebrovascular disease was
assessed as silent brain infarcts (SBI) and white matter hyperintensity volume (WMHV) by brain magnetic
resonance imaging.
R E S U L T S Prevalence of SBI was 15.4%; mean WMHV was 0.66  0.92%. Participants with SBI
showed greater LAVmin (17.1  9.3 ml/m
2 vs. 12.5  5.6 ml/m2, p  0.01) and LAVmax (26.6  8.8 ml/m
2
vs. 23.3  7.0 ml/m2, p  0.01) compared to those without SBI. The LAEV (9.5  3.4 ml/m2 vs. 10.8 
3.9 ml/m2, p  0.01) and LAEF (38.7  14.7% vs. 47.0  11.9%, p  0.01) were also reduced in
participants with SBI. In univariate analyses, greater LA volumes and smaller reservoir function were
signiﬁcantly associated with greater WMHV. In multivariate analyses, LAVmin remained signiﬁcantly
associated with SBI (adjusted odds ratio per SD increase: 1.37, 95% conﬁdence interval: 1.04 to 1.80, p 
0.05) and with WMHV (  0.12, p  0.01), whereas LAVmax was not independently associated with
either. Smaller LAEF was independently associated with SBI (adjusted odds ratio: 0.67, 95% conﬁdence
interval: 0.50 to 0.90, p  0.01) and WMHV (  0.09, p  0.05).
CONC L U S I O N S Greater LA volumes and reduced LA reservoir function are associated with
subclinical cerebrovascular disease detected by brain magnetic resonance imaging in subjects without
history of stroke. In particular, LAVmin and LAEF are more strongly associated with SBI and WMHV than
the more commonly measured LAVmax, and their relationship with subclinical brain lesions is
independent of other cardiovascular risk factors. (J Am Coll Cardiol Img 2013;6:313–24) © 2013 by the
American College of Cardiology Foundation
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314n the United States, the prevalence of stroke in the
population 20 years of age is estimated at 3.0%,
with 7,000,000 people having had a stroke at some
point in their lifetime (1). Brain imaging studies
have revealed that the prevalence of asymptomatic
brain vascular lesions is substantially higher than
clinically overt disease. In the general population,
the prevalence of silent brain infarcts (SBI) has been
estimated from 7% to 28%, with a steep increase
observed with aging (2–8). Cerebral white matter
hyperintensities, often expressed as percent of the
brain volume (white matter hyperintensity volume
[WMHV]), have also been described in asymptom-
atic participants in population studies (9–12). Both
SBI and WMHV have been associated with future
incidence of stroke, cognitive impairment,
and dementia (10,11,13–15).
Increased left atrial (LA) size is associ-
ated with higher mortality and cardiovas-
cular events, including stroke (16–18).
Among measures of LA size, LA volume
appears to provide the best prediction of
adverse prognosis (19). The LA volume
is usually measured in end systole, when
the LA reaches maximum expansion
(LAVmax). Growing evidence, however,
suggests that the analysis of LA volume in
different phases of the cardiac cycle may
provide additional prognostic information.
In particular, the LA minimum (end-
diastolic) volume (LAVmin) and the LA
reservoir function are better predictors of
incident atrial arrhythmias than LAVmax
(20,21). However, it is not known whether
and to what extent parameters of LA size
and function are associated with subclini-
cal cerebrovascular disease. The identifica-
tion of markers of cerebrovascular disease
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tember 18, 2012, accepted October 1, 2012.at an early subclinical stage might improve risk
stratification of people at high cardiovascular risk,
and allow the use of more aggressive therapeutic
strategies to reduce their risk. Accordingly, the aim
of this study was to investigate the relationships of
LA volumes and reservoir function measured by
real-time 3-dimensional (RT3D) echocardiography
with the presence of subclinical cerebrovascular
disease evaluated by magnetic resonance imaging
(MRI) in a community-based cohort.
M E T H O D S
Study population. The CABL (Cardiovascular Ab-
ormalities and Brain Lesions) study is a
ommunity-based epidemiologic study designed to
nvestigate the cardiovascular predictors of silent
erebrovascular disease in the community. The
ABL study based its recruitment on the NOMAS
Northern Manhattan Study), a population-based
rospective study that enrolled 3,298 participants
rom the community living in northern Manhattan
etween 1993 and 2001. The study design and
ecruitment details of NOMAS have been de-
cribed previously (22). Participants were invited to
articipate in an MRI substudy beginning in 2003
nd were eligible for the MRI cohort if they: 1)
ere at least 55 years of age; 2) had no contraindi-
ations to MRI; and 3) did not have a prior
iagnosis of stroke. From September 2005 to July
010, NOMAS MRI participants who voluntarily
greed to undergo a more extensive cardiovascular
valuation were included in the CABL study. Par-
icipants for whom LA volume measurements by
T3D echocardiography and brain MRI informa-
ion were available constitute the final sample of the
resent study. Written informed consent was ob-
ained from all study participants. The study was
pproved by the institutional review boards of
olumbia University Medical Center and of the
niversity of Miami.
Risk factors assessment. Cardiovascular risk factors
ere ascertained through direct examination and
nterview by trained research assistants. Systolic
lood pressure and diastolic blood pressure were
easured at the nondominant arm in sitting posi-
ion after 5 min of rest using a mercury sphygmo-
anometer and a proportioned arm cuff. Study
articipants were not asked to discontinue antihy-
ertensive medications on the day of the visit. Two
lood pressure measurements were performed and
veraged. Hypertension was defined as systolicB B R E V I A T I O N S
N D A C R O N YM S
BMI bodymass index
CAD coronary artery disea
CI confidence interval
LA left atrial
LAEF left atrial total empt
fraction
LAEV left atrial total empt
volume
LAVmax left atrial maximu
volume
LAVmin left atrial minimum
volume
LV left ventricular
MRImagnetic resonance
imaging
OR odds ratio
RT3D real-time 3-dimensi
SBI silent brain infarcts
WMHVwhite matterlood pressure 140 mm Hg or diastolic blood
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315pressure 90 mm Hg at the time of the visit (mean
of two readings), or patient’s self-reported history of
hypertension or of antihypertensive medications.
Diabetes mellitus was defined as fasting blood
glucose 126 mg/dl or patient’s self-reported his-
ory of diabetes or of diabetes medications. Hyper-
holesterolemia was defined as total serum choles-
erol 240 mg/dl, a patient’s self-report of
ypercholesterolemia, or of use of lipid-lowering
reatment. Coronary artery disease (CAD) was
efined as a history of myocardial infarction, coro-
ary artery bypass graft surgery, percutaneous cor-
nary intervention, typical angina, or use of anti-
schemic medications. Cigarette smoking habit,
ither at time of the interview or in the past, was
ecorded. Atrial fibrillation was defined from elec-
rocardiography at the time of echocardiography or
rom self-reported history. Race-ethnicity was
ased on self-identification modeled after the U.S.
ensus.
Echocardiographic assessment. 2-DIMENSIONAL
CHOCARDIOGRAPHY. Transthoracic echocardiog-
aphy was performed using a commercially available
ystem (iE 33, Philips, Andover, Massachusetts) by
trained, registered cardiac sonographer according
o a standardized protocol. Left ventricular (LV)
nd-diastolic diameter (indexed by body surface
rea), interventricular septum thickness, and poste-
ior wall thickness were measured from a paraster-
al long-axis view according to the recommenda-
ions of the American Society of Echocardiography
23). The LV ejection fraction was calculated using
he biplane modified Simpson’s rule, replaced by
emiquantitative method or visual estimation in
ase of technically suboptimal images. The LV mass
as calculated with a validated method (24) and
ndexed by body surface area. The LV relative wall
hickness was calculated as follows: 2  posterior
wall thickness/LV end-diastolic diameter. The LV
diastolic function assessment has been previously
described in detail (25). Briefly, color Doppler
imaging was used to visualize the transmitral flow
from an apical 4-chamber view; the pulsed-wave
Doppler sample volume was placed perpendicular
to the inflow jet at the level of mitral valve leaflet
tips. The peak early velocity (E), late velocity (A),
and deceleration time (DT) of the mitral inflow
were measured, and the E/A ratio was calculated.
Mitral annular velocities were evaluated by pulsed-
wave tissue-Doppler imaging and sampled on the
longitudinal axis from the apical 4-chamber view.
The peak early diastolic velocity (e=) of the lateral
and the septal mitral annulus were measured, and othe average value was calculated. Diastolic dysfunc-
tion was defined as: E/A 0.7 or DT 260 ms; or
E/A between 0.7 and 1.5 and e= 7 cm/s; or E/A
1.5 and e= 7 cm/s or DT 140 ms.
REAL-TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY.
The RT3D imaging was performed using a com-
mercially available ultrasound machine (iE33,
Philips) equipped with an X3-1 matrix array trans-
ducer. A pyramidal full volume dataset was ob-
tained from the acquisition of 4 subvolumes from 4
consecutive cardiac cycles triggered to the R wave of
the electrocardiogram. Sector dimensions and
depth were set to include the whole left ventricle
and the left atrium, allowing volume rates between
15/s and 25/s. Measurement of LA volumes was
performed offline using commercially available soft-
ware (QLAB Advanced Quantification software,
Version 8.1, Philips) by a single reader blinded to
the study participants’ clinical characteristics. A
detailed description of the technique has been
reported previously (26,27). Briefly, 5 anatomical
landmarks (septal, lateral, anterior and inferior mi-
tral annulus, and posterior wall of the left atrium)
were manually identified by the operator, semiau-
tomated border detection was performed by the
software, and LA borders were tracked throughout
the entire cardiac cycle (Fig. 1). Manual correction
on all 3D planes was performed by the reader in
case of inaccurate endocardial detection. The LA
volume measurements were indexed by the body
surface area. The parameters of LA size and func-
tion included in our analyses were as follows:
• LAVmin: LA end-diastolic volume measured at
the first frame after mitral valve closure
LAVmax: LA end-systolic volume measured 1
frame before mitral valve opening
• LAEV: LAVmax  LAVmin, a measure of abso-
lute LA reservoir function
LAEF: 100  (LAVmax  LAVmin)/LAVmax, a
measure of relative LA reservoir function.
Magnetic resonance imaging. A detailed description
f the assessment of subclinical cerebrovascular
esions has been published previously (3,9). Briefly,
rain imaging was performed on a 1.5-T MRI
ystem (Philips Medical Systems). Median time
etween MRI and echocardiographic examination
as 2 days (75th percentile, 5 days). The SBI were
ated by 2 of the authors (C.D., M.Y.) and defined
s either a cavitation on the fluid-attenuated inver-
ion recovery sequence of at least 3 mm in size,
istinct from a vessel (due to the lack of signal void
n T2 sequence), and of equal intensity to cerebro-
S
c
w
c
p
i
r
f
r
c
c
f
r
v
s
a
t
a
t
m
b
c
v
i
s
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 6 , N O . 3 , 2 0 1 3
M A R C H 2 0 1 3 : 3 1 3 – 2 4
Russo et al.
LA Volumes and Subclinical Cerebrovascular Disease
316spinal fluid in the case of lacunar infarction or as a
wedge shaped cortical or cerebellar area of enceph-
alomalacia with surrounding gliosis consistent with
infarction due to distal arterial branch occlusion.
Interobserver agreement for SBI detection was
93.3% (3). The WMHV analysis was based on a
FLAIR (Fluid Attenuated Inversion Recovery) im-
age and performed using the Quantum 6.2 package
on a Sun Microsystems Ultra 5 workstation. The
WMHV was expressed as proportion of total cra-
nial volume to correct for differences in head size,
and log-transformed (log-WMHV) to achieve a
normal distribution for analysis as a continuous
variable. Examples of different forms of subclinical
ischemic lesions are shown in Figure 2. All mea-
surements were performed blinded to participant
identifying and clinical information.
Statistical analysis. Data are presented as mean 
D for continuous variables and as proportions for
ategorical variables. Differences between groups
ere assessed by Student t test and by Pearson
Figure 1. Left Atrial Volumes by Real-Time 3-Dimensional Echoc
(A) Measurement of left atrial maximum volume (LAVmax) and left a
tion was calculated as left atrial total emptying volume (LAEV 
LAVmax).hi-square. Intraclass correlation coefficients and saired student t tests were used to assess reproduc-
bility of echocardiographic measurements. Logistic
egression models were used for the analysis of risk
actors of SBI, and parameter estimates (B), odds
atios (OR) per standard deviation change, and 95%
onfidence intervals (CI) were reported. The asso-
iation of log-WMHV with demographics, clinical
actors, and LA parameters was assessed by linear
egression models. The predictors and the outcome
ariables were standardized with corresponding
tandard deviations and both unstandardized (B)
nd standardized () parameter estimates and rela-
ive standard errors were reported. Two multivari-
te models were built to test the relationship be-
ween LA volumes and SBI/WMHV. The first
odel was adjusted for age, sex, race-ethnicity, and
ody mass index (BMI). For the second model,
ovariates with a p  0.2 for subclinical cerebro-
ascular disease in univariate analysis were entered
n a stepwise fashion with entry and removal criteria
et at p values of 0.2 and 0.3, respectively. For all
iography
l minimum volume (LAVmin). (B) The left atrial (LA) reservoir func-
max  LAVmin) and as LA total emptying fraction (100  LAEV/ard
tria
LAVtatistical analyses, a 2-tailed p  0.05 was consid-
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317ered significant. Statistical analyses were performed
using SAS software, Version 9.2 (SAS Institute,
Cary, North Carolina).
Reproducibility of LA volumes. Reproducibility of
LA volume measurements was assessed in 15 ran-
domly selected subjects. The LAVmin and LAVmax
were remeasured by the original reader and by a
second reader experienced in 3D echocardiography
in a blinded fashion. Intraobserver intraclass corre-
lation coefficients were 0.96 for LAVmin (95% CI:
.88 to 0.99) and 0.94 for LAVmax (95% CI: 0.85 to
.98). The mean difference between 2 measure-
ents was 0.13  1.79 ml/m2 for LAVmin (p 
.78) and 0.42  2.29 ml/m2 for LAVmax (p 
.49). Interobserver intraclass correlation coeffi-
ients were 0.94 for LAVmin (95% CI: 0.85 to 0.98)
nd 0.95 for LAVmax (95% CI: 0.86 to 0.98). The
Figure 2. Subclinical Brain Lesions by MRI
Representative axial magnetic resonance imaging (MRI) slices from
changes, including (B) white matter hyperintensities, (C) cortical infean difference between 2 measurements was 0.44  (.27 ml/m2 for LAVmin (p 0.46) and 0.52 2.56
l/m2 for LAVmax (p  0.45).
R E S U L T S
Characteristics of the study population. For the pres-
nt analysis, 3D analysis of LA volumes and func-
ion was performed in 500 subjects. Image quality
as suboptimal for accurate analysis in 45 (9%),
eading to the final study sample of 455. Clinical
nd demographic characteristics of the study pop-
lation are shown in Table 1. Mean age of the 455
tudy participants was 70.2  10.1 years, mean
MI was 27.7  4.7 kg/m2, and 278 (61.1%) were
omen. Presence of SBI was detected by MRI in
0 of the 455 participants (15.4%); in 10 cases
y participants showing (A) normal brain and subclinical ischemic
ion (arrow), and (D) lacunar infarction (arrow).stud14.3%), the SBI were located in cortical areas, and
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31860 (85.7%) were subcortical. Mean WMHV was
0.66  0.92% (median 0.31%, minimum 0%, max-
mum 5.7%). Prevalence of hypertension was
5.8%, mean systolic blood pressure was 134.7 
7.6 mm Hg, and mean diastolic blood pressure
as 77.9 9.5 mm Hg. Echocardiographic data for
he study population are shown in Table 2.
Cardiovascular risk factors and LA volumes. Hyper-
tension was significantly associated with LAVmax
(r 0.13, p  0.01), LAVmin (r 0.18, p  0.01),
nd LAEF (r  0.18, p  0.01), but not with
AEV (r  0.06, p  0.21). Similarly, systolic
lood pressure was significantly associated with
AVmax (r  0.10, p  0.05), LAVmin (r  0.15,
p  0.01), and LAEF (r  0.19, p  0.01).
Diabetes, hypercholesterolemia, cigarette smoking,
and history of CAD did not show significant
association with LA volumes and function
parameters.
Univariate correlates of subclinical cerebrovascular
disease. The relationships of demographic and
linical characteristics with SBI and WMHV are
hown in Table 3. Presence of SBI was significantly
ssociated with older age (p  0.01), hypertension
p  0.05), diabetes (p  0.05), history of atrial
brillation (p  0.01), LV mass (p  0.01), and
ore than mild mitral regurgitation (p  0.05).
he WMHV was significantly associated with age,
MI, hypertension, atrial fibrillation, LV mass,
elative wall thickness, LV diastolic dysfunction (all
Table 1. Demographic and Clinical Characteristics of the
Study Population (n  455)
Age, yrs 70.2  10.1
Women 278 (61.1)
Body mass index, kg/m2 27.7  4.7
Systolic BP, mm Hg 134.7  17.6
Diastolic BP, mm Hg 77.9  9.5
Hypertension 345 (75.8)
Diabetes mellitus 125 (27.5)
Hypercholesterolemia 289 (63.5)
Atrial ﬁbrillation 25 (5.5)
Coronary artery disease 28 (6.2)
History of cigarette smoking 244 (53.6)
Race-ethnicity
Caucasian 62 (13.6)
Hispanic 314 (69.0)
African American 71 (15.6)
Other 8 (1.8)
Values are mean  SD or n (%).
BP  blood pressure. 0.01), and CAD (p  0.05).LA volumes and reservoir function and subclinical
cerebrovascular disease. Participants with SBI had
greater LAVmin (17.1  9.3 ml/m
2 vs. 12.5  5.6
ml/m2, p  0.01) and greater LAVmax (26.6  8.8
ml/m2 vs. 23.3  7.0 ml/m2, p  0.01) compared
o subjects without SBI. The LAEV (9.5  3.4
l/m2 vs. 10.8  3.9 ml/m2, p  0.01) and LAEF
(38.7  14.7% vs. 47.0  11.9%, p  0.01) were
ignificantly reduced in participants with SBI com-
ared to participants without SBI.
The association of LA volumes and function
ith SBI is shown in Table 4. In unadjusted
nalysis, both LAVmax (OR per SD increase: 1.46,
5% CI: 1.15 to 1.85) and LAVmin (OR: 1.72, 95%
CI: 1.37 to 2.16) were associated with SBI. The
LAVmin remained significantly associated with SBI in
ultivariate models after adjusting for age, sex, BMI,
nd race-ethnicity (OR: 1.47, 95% CI: 1.16 to 1.86)
nd in a model further adjusted for other cardiovas-
ular risk factors and confounders (OR: 1.37, 95% CI:
.04 to 1.80). A LAVmin15.1 ml/m
2 (75th percen-
ile of the distribution) was independently associated
ith a significantly increased risk of SBI (adjusted
R: 2.56, 95% CI: 1.36 to 4.84). The LAVmax lost its
ignificant association with SBI in multivariate mod-
ls. In models including both LA volumes, LAVmin
was still significantly associated with SBI (adjusted
OR: 2.26, 95% CI: 1.34 to 3.83), whereas LAVmax
was not. A reduction in LA reservoir function (LAEV
and LAEF) was significantly associated with SBI in
univariate analyses; in multivariate models, a smaller
LAEF remained significantly associated with SBI
Table 2. 2D and 3D Echocardiographic Data of the
Study Population
2D echocardiography
LV septal thickness, mm 11.4 1.9
LVEDi, mm/m2 26.0 3.2
LV posterior wall thickness, mm 11.1 1.7
LV mass index, g/m2 106.3 27.3
Relative wall thickness 0.49 0.09
LV ejection fraction, % 62.4 8.0
Diastolic dysfunction 247 (54.3)
Heart rate, beats/min 69.6 11.1
Mitral regurgitation (more than mild) 39 (8.6)
3D echocardiography
LAVmax, ml/m
2 23.8 7.4
LAVmin, ml/m
2 13.2 6.5
LAEV, ml/m2 10.6 3.8
LAEF, % 45.7 12.7
Values are mean  SD or n (%).
LAEF  left atrial total emptying fraction; LAEV  left atrial total emptying
volume; LAVmax  left atrial maximum volume; LAVmin  left atrial minimum
volume; LV  left ventricular; LVEDi  LV end-diastolic diameter index.
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319(adjusted OR per standard deviation increase: 0.67,
95% CI: 0.50 to 0.90). A LAEF 37.7 % (25th
ercentile of the distribution) was independently as-
ociated with a significantly increased risk of SBI
adjusted OR: 2.41, 95% CI: 1.31 to 4.41).
Similar results were observed for the association
etween LA volumes and WMHV (Table 5). In
nivariate analyses, LA volumes and LA reservoir
unction parameters were all significantly associated
ith WMHV. In multivariate analyses, however, only
AVmin (  0.12, p  0.01) and LAEF ( 
0.09, p  0.05) showed a significant association
ith WMHV. The LAVmin remained independently
associated with WMHV even when both LA volumes
were included in the same model (  0.18, p 
0.05).
In a subanalysis excluding subjects with atrial
fibrillation and significant mitral regurgitation,
LAVmin confirmed its independent association with
BI (adjusted OR: 1.69, 95% CI: 1.09 to 2.64) and
Table 3. Univariate Correlates of Subclinical Cerebrovascular Di
SBI
B (SE)
Age 0.06 (0.01)
Male 0.2 (0.3)
Body mass index 0.02 (0.03)
Hypertension 0.9 (0.4)
Diabetes mellitus 0.5 (0.3)
Hypercholesterolemia 0.03 (0.27)
Atrial ﬁbrillation 1.6 (0.4)
Coronary artery disease 0.7 (0.5)
Cigarette smoking 0.1 (0.3)
LV mass 0.02 (0.004)
Relative wall thickness 2.4 (1.4)
LV ejection fraction 0.03 (0.01)
LV diastolic dysfunction 0.5 (0.3)
MVR (more than mild) 0.9 (0.4)
Heart rate 0.01 (0.01)
Values are parameter estimates (B) and relative standard error (SE).
LV  left ventricular; MVR  mitral valve regurgitation; SBI  silent brain infa
Table 4. Association of Left Atrial Volumes and Reservoir Funct
Independent Variable
Unadjusted
OR (95% CI) p Value
LAVmax 1.46 (1.15–1.85) 0.01
LAVmin 1.72 (1.37–2.16) 0.01
LAEV 0.68 (0.51–0.90) 0.01
LAEF 0.53 (0.41–0.69) 0.01
Values are odds ratios (OR) per standard deviation increase and 95% conﬁdence
model (covariates: age, hypertension, diabetes, coronary artery disease, atrial ﬁ
diastolic dysfunction, and mitral regurgitation).
Abbreviations as in Tables 2 and 3.ith WMHV (  0.10, p  0.05), whereas
LAVmax did not show significant associations with
ither SBI (adjusted OR: 1.29, 95% CI: 0.87 to
.92) or WMHV (  0.07, p  0.12).
D I S C U S S I O N
The present study investigates for the first time the
relationship of LA volumes and reservoir function
with subclinical cerebrovascular disease. We demon-
strated that greater LA volumes and smaller LA
reservoir function are associated with SBI and
WMHV. In addition, we showed that LAVmin is a
tronger predictor of silent cerebrovascular lesions
han the commonly used LAVmax, and that its signif-
cant association with subclinical brain disease per-
isted after controlling for potential confounders and
isk factors.
The mechanisms linking an increase in LA
olume with cerebrovascular disease are not com-
e
Log-WMHV
p Value B (SE) p Value
0.01 4.7 (0.4) 0.01
0.46 0.9 (9.3) 0.92
0.47 3.4 (1.0) 0.01
0.05 43.0 (10.4) 0.01
0.05 3.3 (10.1) 0.75
0.90 9.9 (9.4) 0.29
0.01 64.6 (20.0) 0.01
0.15 38.7 (18.7) 0.05
0.70 10.3 (9.1) 0.26
0.01 0.8 (0.2) 0.01
0.07 248.1 (48.9) 0.01
0.07 0.9 (0.6) 0.12
0.07 43.6 (8.9) 0.01
0.05 11.3 (16.2) 0.48
0.22 0.2 (0.4) 0.56
WMHV  white matter hyperintensities volume.
With Presence of SBI
Adjusted*
R (95% CI) p Value
Adjusted†
OR (95% CI) p Value
6 (0.99–1.60) 0.06 1.15 (0.88–1.50) 0.32
7 (1.16–1.86) 0.01 1.37 (1.04–1.80) 0.05
3 (0.55–0.97) 0.05 0.77 (0.58–1.02) 0.07
3 (0.48–0.83) 0.01 0.67 (0.50–0.90) 0.01
vals (CI). *Adjusted for age, sex, body mass index, and race-ethnicity. †Stepwise
tion, left ventricular [LV] mass, relative wall thickness, LV ejection fraction, LVseasion
O
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320pletely understood, but it is reasonable to hypoth-
esize that the mechanisms suggested for the rela-
tionship between LA size and stroke may, at least in
part, apply to silent cerebrovascular disease as well.
This is biologically plausible considering that: 1)
subjects with subclinical brain lesions are more
likely to experience an overt cerebrovascular event;
and 2) subclinical and overt cerebrovascular disease
share several common determinants and risk factors
(28), and may therefore share some of their causal
factors. An enlarged LA can be an expression of
hypertension, LV hypertrophy, LV diastolic dys-
function, and increased filling pressure, and is
therefore considered a powerful marker of cardio-
vascular risk (29). The relationship of LA size with
the aforementioned cardiovascular risk factors,
which are in turn associated with atherosclerotic
disease, may represent a link between the enlarge-
ment of the left atrium and the presence of silent
cerebrovascular lesions. Although the etiology of
silent cerebral disease is not completely understood,
arteriosclerotic disease of small penetrating vessels
often appears to be its likely cause. In pathology and
clinical studies, SBI frequently showed the charac-
teristics of lacunes (30), and WMHV were charac-
terized by demyelination and gliosis, presumably
from chronic hypoperfusion of the white matter
(31,32). Several studies have documented the asso-
ciation of silent cerebrovascular lesions with estab-
lished risk factors for arterial atherosclerosis such as
hypertension (4,33), LV hypertrophy (34), smoking
(35), and hyperhomocysteinemia (9,36). The
WMHV have also been shown to be associated
with aortic and carotid atherosclerosis and intima-
medial thickness (37,38). In this view of shared
underlying mechanisms leading to cardiac and ce-
rebral abnormalities, the left atrium can be consid-
ered a strategic component, whose dimension and
function reflect a variety of age- and risk factor–
Table 5. Association of Left Atrial Volumes and Reservoir Funct
Independent
Variable
Unadjusted
B (SE)  p Value B (S
LAVmax 2.6 (0.6) 0.19 0.01 0.8 (
LAVmin 4.2 (0.7) 0.29 0.01 1.6 (
LAEV 2.7 (1.2) 0.11 0.05 1.4 (
LAEF 2.1 (0.3) 0.27 0.01 0.8 (
Values are parameter estimates (B) with relative standard error (SE), and stan
race-ethnicity. †Stepwise model (covariates: age, body mass index, hypertensio
thickness, LV ejection fraction, and LV diastolic dysfunction).
Abbreviations as in Tables 2 and 3.associated changes that also portend the develop-ment of cerebral microvascular perfusion defects
and the resulting subclinical brain disease.
Another possible mechanism linking increased
LA volume and brain lesions is cardioembolism. An
increased LA size is strongly associated with inci-
dent atrial fibrillation and with a higher prevalence
of undetected episodes of paroxysmal atrial fibrilla-
tion (39,40). Atrial fibrillation favors blood stasis
and thrombus formation in the LA appendage,
which can lead to cerebral embolism. In our study,
atrial fibrillation was associated with SBI and
WMHV, and may have been involved in the
association of LA volumes with cerebral lesions.
Our findings, however, remained unchanged after
controlling for the presence of atrial fibrillation in
multivariate models, and even when participants
with atrial fibrillation (and also mitral regurgitation,
a condition directly causative of LA enlargement)
were excluded from the analysis. It is possible,
however, that undetected asymptomatic episodes of
paroxysmal atrial fibrillation in participants with
higher LA volume may have caused cardioembo-
lism that contributed to our findings. The same
consideration applies to participants with lower LA
reservoir function, which has also been found to be
a potent predictor of atrial arrhythmias (20). How-
ever, the number of cortical brain infarcts, generally
considered to be of more likely cardioembolic ori-
gin, was too low (n  10) to perform a separate
analysis by type, which might have strengthened the
hypothesis of cardioembolism as a cause for the
association between LA volumes and SBIs.
So far, the great majority of studies documenting
the prognostic value of LA size considered LAVmax
as an indicator of risk. However, LAVmax represents
he LA volume at the end of LV systolic contrac-
ion, and it is therefore influenced by the systolic
unction of the ventricle. Conversely, LAVmin is
measured at end diastole, when the LA is directly
exposed to the LV pressure. The LAVmin may be
With Log-WMHV
Adjusted* Adjusted†
 p Value B (SE)  p Value
0.06 0.14 0.7 (0.6) 0.06 0.22
0.11 0.05 1.8 (0.7) 0.12 0.01
0.06 0.19 1.3 (1.0) 0.05 0.21
0.11 0.05 0.7 (0.3) 0.09 0.05
ized parameter estimates (). *Adjusted for age, sex, body mass index, and
ronary artery disease, atrial ﬁbrillation, left ventricular [LV] mass, relative wallion
E)
0.6)
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321the chronic LV pressure elevation more accurately
than LAVmax (41); furthermore, LA reservoir func-
tion, besides being negatively affected by LV dia-
stolic dysfunction, is also sensitive to alterations in
LV systolic function (42), and therefore might
represent an integrated marker of risk. Recently, we
demonstrated that LAVmin is indeed a better cor-
elate of LV diastolic function than LAVmax, and
hat the LA reservoir function is strongly affected by
he LV longitudinal systolic function (27); there-
ore, we hypothesized that the weaker relationship
f LAVmax with LV diastolic function may be in
art due to the confounding action of the LV
ystolic function, which can be different among
ersons with similar LV filling pressures, and there-
ore reduce the fit of the relationship between LA
nd-systolic volume and LV diastolic function. In
ine with these considerations, other studies dem-
nstrated that LAVmin and LA reservoir function
re stronger predictors of events and atrial arrhyth-
ias than LAVmax, further confirming that LAVmin
might be a better indicator of LA remodeling and a
better predictor of cardiovascular risk (21,43). Our
findings are in line with these studies, and add novel
evidence indicating that LAVmin and LA reservoir
unction are also strong and independent predictors of
ubclinical cerebrovascular disease.
Our study has potential clinical implications. It is
nown that SBI and WMHV are associated with
uture development of stroke, cognitive impair-
ent, and dementia. In addition to the already
nown association of SBI and WMHV with car-
iovascular risk factors, our study adds LA volume,
AVmin in particular, and LA reservoir function to
the correlates of subclinical cerebrovascular disease.
A more aggressive clinical management of subjects
with risk factors and with increased LA volume or
reduced LA reservoir function might, therefore, be
potentially helpful in reducing future clinical man-
ifestations of cerebrovascular disease, although fur-
ther studies are required to confirm this approach.
The assessment of LA phasic volumes is not part of
standard clinical practice. The demonstration that
LAVmin and LAEF are better predictors of subclin-
ical cerebrovascular disease than the commonly
utilized LAVmax adds to existing evidence in favor
f adopting a more comprehensive assessment of
A mechanics, which might allow early identifica-
ion of subjects with subclinical signs of cerebral
isease and refine risk stratification. Although
-dimensional echocardiography can provide accu-
ate assessment of LA volume and function and is
till the method of choice for many laboratories, dodern RT3D echocardiography, with its semiau-
omated endocardial border detection algorithms,
llows easy and fast evaluation of LA mechanics,
nd after adequate operator training, can provide
eproducible data with an acceptable offline analysis
ime (44). In particular, the intraobserver and in-
erobserver reproducibility of LAVmin in our study
was excellent and comparable to that of LAVmax;
herefore, we do not confirm the finding of lower
eproducibility of LAVmin observed in a previous
tudy (21).
Study strengths and limitations. The strengths of our
study include the relatively large number of subje-
cts studied with advanced imaging techniques
(RT3D echocardiography and brain MRI), the low
risk of selection bias (the study sample was drawn
from a community-cohort study that employed
random selection of participants), the wide range of
cardiovascular risk profiles present in our study
population, and the confirmation of our findings
after adjustment for appropriate covariates. How-
ever, our study also has limitations. Because the
study population included subjects 50 years of
age, our results may not apply to younger popula-
tions. However, silent brain disease is more com-
monly found among the elderly, which made our
study cohort an ideal setting for this study. Our
study population had high frequency of cardiovas-
cular risk factors and was in large part of Hispanic
ethnicity, circumstances that might preclude the
generalization of our findings to populations with
lower cardiovascular risk and different race-ethnic
composition. Finally, because of the cross-sectional
design of our study, we cannot examine cause-effect
relationships, but only document associations.
C O N C L U S I O N S
In our community cohort, LA volume and reservoir
function were associated with silent brain infarcts
and white matter hyperintensities. The LAVmin
showed stronger association with subclinical cere-
brovascular disease than the LAVmax, and this
association was independent of traditional cardio-
vascular risk factors and potential confounders. The
observation that LAVmin is more strongly corre-
lated to subclinical cerebrovascular disease than
LAVmax, together with its closer correlation with
LV diastolic function and greater ability to predict
atrial arrhythmias observed in previous studies,
suggests that LAVmin may be a better marker of LA
emodeling and cardiovascular risk. The echocar-
iographic evaluation of LA volume at end diastole
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322and of the LA reservoir function in clinical practice
may improve the prognostic assessment of subjects
at risk of cardiovascular events.
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